July 24th, 2009 by admin

The FIRST Clinical Research Organisation to conduct a Phase I trial in healthy young people aged 14-17!

On the 12th February 2009 Richmond Pharmacology became the first CRO in Europe to gain ethics approval to conduct a Phase I healthy volunteer trial in healthy young females aged 14-17.

Richmond Pharmacology also provides Clinical Data Management Services for clinical trials

Great Ormond Street Ethics Committee made the decision to permit this clinical trial and since then has allowed further studies of this nature to take place

The first subjects were dosed into this study on the 28th February 2009, just 16 days after gaining ethics approval, an achievement in itself.

The study being conducted by Richmond Pharmacology aims to determine the effect a study drug, (a new oral contraceptive pill), has on the body and if there is a difference in what happens to the drug in females aged 18-50 compared to females aged 14-17.

The study itself is typical of many Phase I trials of these compounds, however it is the population being incorporated that makes this a key study.

The UK has been known to conduct top class clinical trials and studies for all phases   Recently some of these trials have been conducted outside of the UK However the approval of this study marks a substantial shift in thinking and attitude towards clinical trial conduct in the UK and Richmond Pharmacology are proud to be at the centre of this pioneering move to once again make the UK THE place to conduct more specialised clinical trials

In addition to providing high quality full service clinical studies, Richmond Pharmacology now has the proven ability to conduct a wide variety of studies complicated in their design and population required.

Richmond Pharmacology’s founding Directors are still at the heart of the company. Their hands on approach coupled with a dedicated and highly skilled staff ensure we are able to meet the challenges set by sponsors.